Application note

Rapid quality control of commercially available antibodies by MDS for acceptance testing

Size presents a simple metric to assess quality as an indicator of aggregation and degradation. Here MDS on the Fluidity One and SEC analysis are both used to check 6 commercially available antibodies.

  • Find out how MDS gave results in 80% less time than SEC analysis

  • How MDS used 90% less time to run the samples

  • Publications and resources

    View all
    • Publication

      PEGS Boston 2019 poster

      Download a copy of our poster as shown at PEGS 2019 here, titled; Microfluidic Diffusional Sizing (MDS) for protein characterization – latest results and next steps.

Sounds like this could support your research?

Get in touch, our applications scientists will be happy to discuss your lab's protein research needs.

Learn more